NCT00000304
Completed
Phase 2
Dextroamphetamine as an Adjunct in Cocaine Treatment
Overview
- Phase
- Phase 2
- Intervention
- Dextroamphetamine
- Conditions
- Cocaine-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- verifiable cocaine abstinence
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
1
15/30 mg d-amphetamine
Intervention: Dextroamphetamine
2
30/60 mg d-amphetamine
Intervention: D-Amphetamine
3
placebo
Intervention: Placebo
Outcomes
Primary Outcomes
verifiable cocaine abstinence
Time Frame: 16 weeks of study
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3Cocaine-Related DisordersOpioid-Related DisordersNCT00000306National Institute on Drug Abuse (NIDA)140
Completed
Phase 2
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and PlaceboCocaine-Related DisordersNCT00218348The University of Texas Health Science Center, Houston186
Terminated
Phase 2
Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)Attention Deficit Disorder With HyperactivityCocaine-Related DisordersSubstance-Related DisordersNCT00514202The University of Texas Health Science Center, Houston5
Terminated
Phase 1
Amphetamine Cocaine Interaction Study - 2Cocaine-Related DisordersNCT00000305The University of Texas Health Science Center, Houston
Completed
Phase 2
Dextroamphetamine-Cocaine Behavioral Intervention - 5Cocaine-Related DisordersNCT00000308National Institute on Drug Abuse (NIDA)54